1

ICONQuarter 2, 2008 Results ended June 30, 2008

Dr. John Climax, Chairman

Mr. Peter Gray, CEO

Mr. Ciaran Murray, CFO

2

Certain statements contained herein including, without limitation,

statements containing the words “believes,” “anticipates,” “intends,”

“expects” and words of similar import, constitute forward-looking

statements concerning the Company's operations, performance,

financial condition and prospects. Because such statements involve

known and unknown risks and uncertainties, actual results may differ

materially from those expressed or implied by such forward-looking

statements. Given these uncertainties, prospective investors are

cautioned not to place undue reliance on such forward-looking

statements. The Company undertakes no obligation to publicly update

or revise any forward-looking statements, whether as a result of new

information, future events or otherwise.

Forward Looking Statement

3

$147.0m

$166.9m$180.7m

$218.3m$201.3m

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

Quarterly Net Revenue Growth

4

$16.1m$18.7m

$19.8m$21.5m

$24.4m

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

Quarterly Operating Income

5

10.9%11.2% 11.0%

10.7%11.2%

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

Quarterly Operating Margins

6

11.3% 11.6% 11.3% 11.0%11.5%

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

Quarterly Clinical Core Operating Margin

7

Quarterly Central Laboratory Operating Margin

6.6% 7.0% 7.0% 7.5% 7.8%

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

8

56c53c49c

45c

62c

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

$14.5m$13.3m

$15.8m$16.9m

$18.8m

Quarterly Earnings per Share and Net Income

9

June 30, 2008 Mar 31, 2008 Dec 31, 2007

Net Cash/(Debt) 6.9 (20.2) 23.8

Net Accounts

Receivable 202.4 210.0 178.0

DSOs 58 Days 67 Days 66 Days

Balance Sheet$ million

10

Outlook

11

$366m

$264m

$246m

$440m

$393m

$230m

$230m

$344m $369m$337m

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

Gross AwardsNet Awards

Business Wins

12

$1,633m$1,486m

$1,300m$1,125m$1,049m

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

Total Backlog

13

$752m

$690m

$589m

$542m

$493m

Q2 2007 Q3 2007 Q4 2007 Q1 2008 Q2 2008

76%77% 77%76%

79%

Backlog forecast to be earned in the next12 months (US$ & % of total forecasts)

77%

14

Prior Guidance Revised Guidance(issued April 29, 08) (issued July 22, 08)

Revenue $840 - 860m $870 - 890m

EPS $2.35 – $2.45 $2.46 – $2.52

Guidance increased

15

Questions &

Answers

Dr John Climax, Chairman

Mr Peter Gray, CEO

Mr Ciaran Murray, CFO

16

Q2 net revenues ↑ 48.5%

Q2 income from operations ↑ 51.9%

Q2 EPS ↑ 37.7%

$337 million of net new business wins

Book-to-bill ratio 1.5

Guidance raised revenue $870 - $890m and EPS $2.46 - $2.52

Summary Quarter 2, 2008